|

Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions

RECRUITINGN/ASponsored by Instituto do Cancer do Estado de São Paulo
Actively Recruiting
PhaseN/A
SponsorInstituto do Cancer do Estado de São Paulo
Started2025-02-01
Est. completion2026-02-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07066046

Summary

The study aims to evaluate the effectiveness of artificial intelligence-assisted colonoscopy in increasing adenoma detection rate and the accuracy in the characterization of colorectal lesions, compared to standard colonoscopy, in a randomized controlled clinical trial setting.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* All patients aged 18 years or older, with an elective indication for colonoscopy who sign the informed consent form agreeing to participate in the study.

Exclusion Criteria:

* History of inflammatory bowel disease.
* History of colorectal cancer.
* Personal history of colorectal surgery.
* Contraindication to endoscopic biopsies.
* History of intestinal polyposis syndromes.
* Urgent or emergency cases.
* Presence of severe, decompensated comorbidities, or with a score of 3 or higher according to the American Society of Anesthesiologists (ASA) classification.
* Incomplete colonoscopy that does not reach the cecum.
* Insufficient or inadequate bowel preparation, with a score lower than 6 on the Boston Bowel Preparation Scale.
* Patients who do not agree to participate in the study and do not sign the informed consent form (ICF).

Conditions5

Adenomatous PolyposisCancerColorectal CancerColorectal Cancer (CRC)Colorectal Lesions

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.